rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Richard G. Vincent

Director

Company insider

Files Form 4 as: Director, Forte Biosciences; Chief Financial Officer, Oncternal Therapeutics; Executive Vice President & CFO, Sorrento Therapeutics.

Every Form 4 they filed

In numbers

Trades disclosed
58
Buys
6
Sells
0
Bought
$38K
Sold
$0
Companies
3
Companies where not an officer
1
First trade
5 Feb 2010
Last trade
27 Aug 2026
Last filed
27 Aug 2026

Companies traded

Where they are an officer
Oncternal TherapeuticsOfficer · last 14 Feb 20246 buys · 0 sells
Sorrento TherapeuticsDirector, Officer · last 7 Oct 20140 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
Forte BiosciencesDirector · Biotechnology · last 27 Aug 20260 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—2,000filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—31,000filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—18,353filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—2,000filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—31,000filing
27 Aug 2026filed 27 Aug 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code D—18,353filing
29 May 2026filed 2 Jun 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—18,353 at $0.00filing
29 May 2026filed 2 Jun 2026Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—18,353 at $0.00filing
20 Mar 2025filed 21 Mar 2025Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—31,000 at $0.00filing
17 Sep 2024filed 19 Sep 2024Forte Biosciencesoption or derivative · BiotechnologySEC FORM 4 Code A—2,000 at $0.00filing
14 Feb 2024filed 15 Feb 2024Oncternal Therapeuticsoption or derivativeSEC FORM 4 Code A—14,200 at $0.00filing
3 Jan 2024filed 5 Jan 2024Oncternal TherapeuticsSEC FORM 4 Code F$4,4348,868 at $0.50filing
2 Oct 2023filed 4 Oct 2023Oncternal Therapeuticsoption or derivativeSEC FORM 4 Code D—75,000filing
2 Oct 2023filed 4 Oct 2023Oncternal Therapeuticsoption or derivativeSEC FORM 4 Code D—35,120filing
2 Oct 2023filed 4 Oct 2023Oncternal Therapeuticsoption or derivativeSEC FORM 4 Code D—280,000filing
2 Oct 2023filed 4 Oct 2023Oncternal Therapeuticsoption or derivativeSEC FORM 4 Code D—109,579filing
2 Oct 2023filed 4 Oct 2023Oncternal Therapeuticsoption or derivativeSEC FORM 4 Code D—28,750filing
2 Oct 2023filed 4 Oct 2023Oncternal Therapeuticsoption or derivativeSEC FORM 4 Code D—210,000filing
2 Oct 2023filed 4 Oct 2023Oncternal Therapeuticsoption or derivativeSEC FORM 4 Code A—75,000filing
2 Oct 2023filed 4 Oct 2023Oncternal Therapeuticsoption or derivativeSEC FORM 4 Code A—35,120filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed6

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.